NCT03807037View on ClinicalTrials.gov

Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Atrial Fibrillation
Interventions
DIETARY_SUPPLEMENT

Tocotrienols

Mixed tocotrienols (derived from palm oil) to be orally administered at 200mg (1 capsule) twice daily, to achieve dosage of 400mg/day

DRUG

Placebo oral capsule

Matching placebo to be administered orally at 1 capsule, twice daily

Trial Locations (1)

50400

Institut Jantung Negara, Kuala Lumpur

All Listed Sponsors
collaborator

Institut Jantung Negara

OTHER

lead

Monash University Malaysia

OTHER

NCT03807037 - Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation | Biotech Hunter | Biotech Hunter